Advocacy intelligence hub — real-time data for patient organizations
Lutrepulse: FDA approved
For induction of ovulation in women with hypothalamic amenorrhea due to a deficiency or absence in the quantity or pulse pattern of endogenous GnRH secretion.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Lutrepulse
Ferring Laboratories, Inc.
Lutrepulse
(Gonadorelin acetate)Orphan drugFerring Laboratories, Inc.